Dry eye disease (DED)
The Prevalence and Risk Factors for Dry Eye Disease among Older Adults in the City of Lodz, Poland
5
The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial
7
Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study
10
Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops
5
Tear film osmolarity and dry eye disease: a review of the literature
9
Intense pulsed light for evaporative dry eye disease
7
Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction
11
Association of dry eye disease with psychiatric or neurological disorders in elderly patients
8
Alteration of Galectin-3 in Tears of Patients With Dry Eye Disease
24
Defining the needs and preferences of patients with dry eye disease
8
The association of sleep quality with dry eye disease: the Osaka study
7
Dry eye disease after refractive surgery
5
Diagnosis of dry eye disease and emerging technologies
10
Fluorophotometry as a diagnostic tool for the evaluation of dry eye disease
7
Etiology, prevalence, and treatment of dry eye disease
8
Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study
8
Sex differences in the effect of aging on dry eye disease
8
Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED)
6
New drugs for the treatment of dry eye disease
12
Corneal permeability changes in dry eye disease: an observational study
6